The Medical Field has lost a great national and international stature.
The family of Galala University offers their most profound and sincere condolences to Prof.Dr. Ashraf Haidar Ghaleb, Acting President of the University, on the loss of his father, Prof.Dr. Haidar Ghaleb, Professor Emeritus of Clinical Pharmacology and Therapeutics at the Faculty of Medicine, Cairo University.
The Late Prof. Ghaleb held several academic positions, including Emeritus Professor of Clinical Pharmacology & Therapeutics Faculty of Medicine, Cairo University; Consultant of Pediatrics (Private practice); General Secretary, The Medical Sector at the Supreme Council of Egyptian Universities, Chairman of the Egyptian Society of Medical Ethics; Vice President (Postgraduate, Development, and Research), Menoufia University from 1987 to 1990. He also held the positions of Founding Dean, Faculty of Medicine, University of Menoufia, Egypt from 1984 to 1987 & Professor of Pharmacology and Therapeutics and Chairman of the Department of Pharmacology, Faculty of Medicine, Cairo University from 1974 to 1984.
Other than the faculty of Medicine, He also held many national and international Positions; as a WHO Consultant; Consultant to the national pharmaceutical Industries; Chancellor for the Egyptian Ministry of Health from 1992 to 1995; Chairman of the Egyptian Drug Registration and Safety Committee, Ministry of Health From 1978 to 1982; Member of the Academy of Sciences in Cairo, Egypt and Member of the board of the AMEEMR, World Federation for Medical Education; Member of the International Society of Cytokines & Interferon.
He also received many scientific awards, including the Discovery of The Halphabarol (Proximol) award to eliminate ureter stones in 1972. He also won the Gold Medal of the Geneva Patent Organization to invent the drug "Proximol" and its applications in patients' treatment in 1984. In 1988, he patented a method for isolating natural Human leukocytic Alfa Interferons from the European Union, which has been later sold in the Egyptian market under the commercial name ISMAFERON ®️, ACAPI-Egypt.
The late Prof.Dr. Ghaleb has a vast scientific heritage, including more than 100 Egyptian and international medical journals. He has published seven studies on various aspects of pharmacology and clinical pharmacology and has overseen more than 50 Doctoral degrees and more than 40 Master's thesis.